排序方式:
    總頁 2 
      Go

    1.Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    Vallejo-Vaz, AJ, De     More...

    ATHEROSCLEROSIS[0021-9150], Published 2018, Volume 277, Pages 234-255

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 138  2022影響因子:  5.3  发表年影響因子:  4.255 

    2.Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia

    Hagger, MS, Hardcast     More...

    ATHEROSCLEROSIS[0021-9150], Published 2018, Volume 277, Pages 493-501

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 15  2022影響因子:  5.3  发表年影響因子:  4.255 

    3.SEVERE HYPERTRIGLYCERIDEAMIA RELATED TO A NOVEL MUTATION IN TRIB1 AND A KNOWN VARIANT IN APOA5

    Tomlinson, B, Hu, M,     More...

    ATHEROSCLEROSIS[0021-9150], Published 2017, Volume 263, Pages E230-E230

    收錄情况: WOS

    2022影響因子:  5.3  发表年影響因子:  4.467 

    4.SEVERE FAMILIAL HYPERCHOLESTEROLAEMIA IN TWO BROTHERS WITH THREE HETEROZYGOUS CODING MUTATIONS IN LDLR

    Tomlinson, B, Hu, M,     More...

    ATHEROSCLEROSIS[0021-9150], Published 2017, Volume 263, Pages E230-E230

    收錄情况: WOS

    2022影響因子:  5.3  发表年影響因子:  4.467 

    5.GENETIC VARIANTS AND LIPID TRAITS IN THE HONG KONG CHINESE PATIENTS WITH TYPE 2 DIABETES

    Hu, M, Tam, C, So, W     More...

    ATHEROSCLEROSIS[0021-9150], Published 2016, Volume 252, Pages E148-E148

    收錄情况: WOS

    2022影響因子:  5.3  发表年影響因子:  4.239 

    6.GENETIC, OMICS AND IN SILICO APPROACHES. RARE VARIANTS IN ABCG2 IDENTIFIED BY SEQUENCING MAY INFLUENCE THE LIPID RESPONSE TO ROSUVASTATIN TREATMENT

    Hu, M, Chan, J, Toml     More...

    ATHEROSCLEROSIS[0021-9150], Published 2016, Volume 252, Pages E202-E203

    收錄情况: WOS

    2022影響因子:  5.3  发表年影響因子:  4.239 

    7.IS THERE A ROLE FOR NIACIN IN FAMILIAL HYPERCHOLESTEROLAEMIA?

    Hu, M, Yang, YL, Mas     More...

    ATHEROSCLEROSIS[0021-9150], Published 2015, Volume 241, Issue 1, Pages E109-E109

    收錄情况: WOS

    2022影響因子:  5.3  发表年影響因子:  3.942 

    8.INFLUENCE OF FARNESOID X RECEPTOR AND BILE ACID TRANSPORTER POLYMORPHISMS ON THE PHARMACOKINETICS OF URSODEOXYCHOLIC ACID

    Hu, M, Fok, B, Wo, S     More...

    ATHEROSCLEROSIS[0021-9150], Published 2015, Volume 241, Issue 1, Pages E118-E118

    收錄情况: WOS

    2022影響因子:  5.3  发表年影響因子:  3.942 

    9.DGAT1 AND DGAT2 POLYMORPHISMS HAD NO EFFECT ON THE LIPID RESPONSES TO NIACIN IN CHINESE PATIENTS WITH DYSLIPIDAEMIA

    Hu, M, Yang, Y, Ng,     More...

    ATHEROSCLEROSIS[0021-9150], Published 2014, Volume 235, Issue 2, Pages E256-E256

    收錄情况: WOS

    2022影響因子:  5.3  发表年影響因子:  3.994 

    10.EFFECT OF NIACIN ON OXIDIZED LOW-DENSITY LIPOPROTEIN LEVELS IN CHINESE PATIENTS WITH DYSLIPIDAEMIA

    Hu, M, Yang, Y, Yama     More...

    ATHEROSCLEROSIS[0021-9150], Published 2014, Volume 235, Issue 2, Pages E256_E256

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  5.3  发表年影響因子:  3.994 

    11.Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia

    Hu, M, Tomlinson, B

    ATHEROSCLEROSIS[0021-9150], Published 2012, Volume 223, Issue 2, Pages 427-432

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 13  2022影響因子:  5.3  发表年影響因子:  3.706 

    12.A polymorphism in transforming growth factor-beta 1 is associated with carotid plaques and increased carotid intima-media thickness in older Chinese men: The Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort

    Deng, HB, Jiang, CQ,     More...

    ATHEROSCLEROSIS[0021-9150], Published 2011, Volume 214, Issue 2, Pages 391-396

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 16  2022影響因子:  5.3  发表年影響因子:  3.794 

    13.Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese

    Liu, ZK, Hu, M, Baum     More...

    ATHEROSCLEROSIS[0021-9150], Published 2010, Volume 208, Issue 2, Pages 427-432

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 34  2022影響因子:  5.3  发表年影響因子:  4.086 

    14.Atorvastatin treatment-related changes to in vivo oxidant: Antioxidant balance as assessed by plasma allantoin and lipid standardised vitamin E levels

    Benzie, IFF, Tomlins     More...

    ATHEROSCLEROSIS[0021-9150], Published 1999, Volume 144, Pages 25-26

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  5.3  发表年影響因子:  2.877 

    15.Effects of atorvastatin on platelet aggregation in whole blood

    Fan, B, Tomlinson, B     More...

    ATHEROSCLEROSIS[0021-9150], Published 1999, Volume 144, Pages 35-35

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  5.3  发表年影響因子:  2.877 

    16.Bioavailability of antioxidant power in green tea

    Benzie, IFF, Szeto,     More...

    ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S35-S35

    收錄情况: WOS

    2022影響因子:  5.3  发表年影響因子:  2.885 

    17.Response to bezafibrate in combined hyperlipidaemia

    Lan, W, Tomlinson, B     More...

    ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S55-S55

    收錄情况: WOS

    2022影響因子:  5.3  发表年影響因子:  2.885 

    18.Combination treatment with fluvastatin and gemfibrozil in resistant hyperlipidaemia

    Tomlinson, B, Wong,     More...

    ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S56-S56

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  5.3  发表年影響因子:  2.885 

    19.Familial hypercholesterolaemia in Hong Kong

    Tomlinson, B, Lan, W     More...

    ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S59-S59

    收錄情况: WOS

    2022影響因子:  5.3  发表年影響因子:  2.885 

    20.Investigation of mutations and polymorphisms in the lipoprotein lipase gene

    Chan, YS, Tomlinson,     More...

    ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S67-S67

    收錄情况: WOS

    2022影響因子:  5.3  发表年影響因子:  2.885 

    顯示      條  合計   25   條
      總頁 2 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫